Clinical Trials Logo

Typhoid clinical trials

View clinical trials related to Typhoid.

Filter by:

NCT ID: NCT00131820 Completed - Typhoid Clinical Trials

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Start date: December 2001
Phase: Phase 4
Study type: Interventional

This study is part of International Vaccine Institutes (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The primary objectives of the study are to evaluate the logistic feasibility of a mass typhoid fever immunization campaign program targeting school age children in Hue City, Vietnam and to assess the knowledge, attitudes, beliefs, and practices of parents and healthcare providers in Hue City regarding typhoid fever prevention and treatment.

NCT ID: NCT00125047 Completed - Typhoid Clinical Trials

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Start date: October 2001
Phase: Phase 4
Study type: Interventional

This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The purpose of this study is to determine the effectiveness of the Vi vaccine following a mass typhoid immunization campaign in an endemic area in Karachi, Pakistan. The cost-effectiveness of Vi vaccination and the logistic feasibility of a mass typhoid immunization campaign will also be evaluated.

NCT ID: NCT00125008 Completed - Typhoid Clinical Trials

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Start date: May 2003
Phase: Phase 4
Study type: Interventional

This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The purpose of this study is to determine the effectiveness of the Vi vaccine following a mass typhoid immunization campaign in an endemic area in Kolkata, India. The cost-effectiveness of the Vi vaccination and the logistic feasibility of a mass typhoid immunization campaign will also be evaluated.